Dr. Reddy's Laboratories starts supply of Sputnik V first doses to partner hospitals

08 Sep 2021 Evaluate

Dr. Reddy's Laboratories has initiated supply of the first dose component of Russian COVID-19 vaccine Sputnik V to partner hospitals all over the country. The development came following the announcement that Panacea Biotec supplied the first shipment of the second component of the Russian Sputnik V vaccine manufactured by it for sale in India. Dr Reddy's earlier suspended the supply of the first dose of Sputnik V following supply constraints from Russian Direct Investment Fund.

The supply of the first does is followed by equivalent quantities of the second dose component. The company has also launched website to keep the public updated on the availability of the Sputnik V vaccine the site (www.drreddys.com/sputnik-vaccine) contains a list of cities, towns and hospitals where the vaccine is available.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1287.20 -31.70 (-2.40%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×